Biosafety

Biosafety

Biosafety

Don't forget about export controls when doing international shipments.

Recent times where things went wrong

Department of Commerce Fines Princeton University $54,000 (pdf) for shipping internationally various strains and recombinants of animal pathogens from the United States to various overseas research institutions without the required export licenses.

 

The Institutional Biosafety Committee (IBC) is responsible for reviewing all University research and teaching activities involving the use of biohazards, recombinant DNA molecules, select agents, or bloodborne pathogens whether the activities are carried out on campus or off campus (usually under other Institutional Biosafety Committees).

The IBC will review and authorize for 3 years, research involving: human pathogens; human blood, body fluids, or tissues; animal pathogens; plant pathogens; biological toxins;  infected animals or tissues (including field work), recombinant DNA, or Select Agents & Toxins. Most biological research requires IBC authorization prior to initiation.

In addition the IBC provides oversight for biological agents which might fall under the Dual Use Research of Concern.  

All questions and inquiries can be made at Wendy Haggren (whaggren@uccs.edu) 719-255-4156 or Cynthia Norton (cnorton@uccs.edu) at 719-255-3212.

IBC Forms

  • When to Use

    Required for all IBC applications


    Revision Date

    Sep 2020


    IBC Application (MS word document)

  • When to Use

    • Use of recombinant or synthetic nucleic acid molecules (e.g., Use of GFP inserts)
    • GeneTherapy/Vaccine Experiment/Use of Human Research Participant

    Revision Date

    Oct 2020


    IBC Attachment II-A (MS word document)

  • When to Use

    • Use of biohazardous agents and Toxins (except those listed below)>
    • Use of infected or potentially infected cell lines , tissue or bodily fluids (except those listed below), primary cells>
    • Use of animal cell lines, infected or potentially infected tissue or bodily fluids

    Those items not requiring use of this form

    • Use of human blood or blood products like serum, plasma or cell preparation or other bodily fluids (i.e. urine) which are not known or anticipated to be infected

    Revision Date

    July 2017

    IBC Attachment II-B  (MS word document)

  • When to Use

    Use of transgenic and/or pathogenic plants


    Revision Date

    Oct 2020


    Attachement II-C (MS Word Document)

  • When to Use

    Use of recombinant or synthetic nucleic acid molecules (e.g., Use of GFP inserts)


    Revision Date

    Oct 2020


    IBC Attachment II Worksheet 1 (MS word document)

  • When to Use

    If your research involves animals and use of recombinant or synthetic nucleic acid molecules (e.g., Use of GFP inserts) or

    If your research involves of CDC/USDA Select Agents/Toxins and use of laboratory animal subjects with Biological Agents/Cells/Materials


    Revision Date

    Oct 2020


    IBC Attachment II Worksheet 2 (MS word document)

  • When to Use

    The Addendum form can be used for less significant updates, such as those involving changes in personnel, or locations.

     


    Revision Date

    Oct 2020


    IBC Biosafety Application Addendum Form (MS word document)

  • When to Use

    Annual confirmation of continued research and personnel updates


    Revision Date

    Oct 2020


    IBC Biosafety Annual Update Form (MS word document)

Biosafety Resources


IBC Biosafety Training


All Principal Investigators, staff and students involved in Biosafety related activities are required to be trained - go here to find out more


Risk Group Database

 


Select Agents


Guidance Document for Select Agents

Select Agent List